As EMT plays a key role in cholangiocarcinoma metastasis, we examined the effects of M3-mAChR agonist and antagonist treatment on the expression of EMT factors related to the PI3K/AKT pathway in RBE cells. This evidence concerns the gene AKT1 and cholangiocarcinoma.